Pancreatic Cancer Research

ResearcherKanazawa UniversityActive in the last 2 years

Yoshio Sakai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0377-6130; OpenAlex author ID A5059485526. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 10

  1. Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer. Co-author DOI 10.1002/1878-0261.13796↗
  2. Efficacy of a novel self-expandable metal stent with dumbbell-shaped flare ends for distal biliary obstruction due to unresectable pancreatic cancer. Co-author DOI 10.1038/s41598-022-25186-2↗
  3. Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.jcyt.2020.08.001↗
  4. Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors. Co-author PMID 34249452↗
  5. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer … Last author DOI 10.1136/jitc-2020-001367↗
  6. Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiation. First author DOI 10.1080/09553002.2019.1558297↗
  7. Distinct chemotherapy-associated anti-cancer immunity by myeloid cells inhibition in murine pancreatic cancer models. Co-author DOI 10.1111/cas.13944↗
  8. Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells. Co-author DOI 10.1111/cas.13971↗
  9. Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1111/cas.13396↗
  10. Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impact. First author DOI 10.1111/cas.12663↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taro Yamashita · 7 shared papers, 2019–2025 · strength 0.85
  2. Shuichi Kaneko · 8 shared papers, 2015–2025 · strength 0.81
  3. Alessandro Nasti · 5 shared papers, 2019–2025 · strength 0.57
  4. Akihiro Seki · 3 shared papers, 2019–2025 · strength 0.42
  5. Tuyen Thuy Bich Ho · 3 shared papers, 2019–2025 · strength 0.42
  6. Takuya Komura · 5 shared papers, 2015–2020 · strength 0.36
  7. Masaki Miyazawa · 3 shared papers, 2017–2022 · strength 0.27
  8. Takeshi Terashima · 3 shared papers, 2019–2021 · strength 0.26
  9. Shuichi Kaneko MD · 2 shared papers, 2021 · strength 0.22
  10. Hiroki Matsukawa · 1 shared paper, 2021 · strength 0.11
  11. Isamu Makino · 1 shared paper, 2021 · strength 0.11
  12. Tetsuo Ohta · 2 shared papers, 2015–2017 · strength 0.11
  13. Tatsuo Kumai · 1 shared paper, 2021 · strength 0.11
  14. Shigenori Goto · 1 shared paper, 2021 · strength 0.11
  15. Tomoharu Miyashita · 1 shared paper, 2021 · strength 0.11
  16. Haruo Fujinaga · 1 shared paper, 2019 · strength 0.08
  17. Shigeyuki Matsui · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.